Home Blood Pressure Intervention in the Community Trial
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The primary purpose of the study is to explore whether a lower home blood pressure target (125/75 v.s. 135/85 mmHg) would be beneficial to elderly treated hypertensive patients in terms of reduced incidence of cardiovascular events. The study also aims to promote the application of standardised and information-based home blood pressure monitoring in community hypertension management.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 60
Maximum Age: 80
Healthy Volunteers: f
View:
• Aged 60-80 years old
• Have been taking antihypertensive drugs for more than 2 weeks
• The average SBP and/or DBP of 7-day home blood pressure monitoring ≥135/85 mmHg
• Willing to participate, adhere to follow-up, and sign the written informed consent form
Locations
Other Locations
China
Community hospitals
RECRUITING
Shanghai
Contact Information
Primary
Yan Li, Professor
liyanshcn@163.com
+8613482234463
Time Frame
Start Date: 2023-05-06
Estimated Completion Date: 2030-06-30
Participants
Target number of participants: 10000
Treatments
Experimental: Intensive Home BP Control
Participants randomized into the intensive treatment arm will have a goal of home BP\<125/75 mmHg.
Active_comparator: Standard Home BP Control
Participants randomized into the standard treatment arm will have a goal of home BP within 125-134/75-84 mmHg.
Related Therapeutic Areas
Sponsors
Leads: Shanghai Institute of Hypertension